|
1
|
WHO Coronavirus (COVID-19) Dashboard.
|
|
2
|
Bodnar B, Patel K, Ho W, Luo JJ and Hu W:
Cellular mechanisms underlying neurological/neuropsychiatric
manifestations of COVID-19. J Med Virol. 93:1983–1998.
2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Rogers JP, Chesney E, Oliver D, Pollak TA,
McGuire P, Fusar-Poli P, Zandi MS, Lewis G and David AS:
Psychiatric and neuropsychiatric presentations associated with
severe coronavirus infections: A systematic review and
meta-analysis with comparison to the COVID-19 pandemic. Lancet
Psychiatry. 7:611–627. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Moldofsky H and Patcai J: Chronic
widespread musculoskeletal pain, fatigue, depression and disordered
sleep in chronic post-SARS syndrome; a case-controlled study. BMC
Neurol. 11(37)2011.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Hoffmann M, Kleine-Weber H, Schroeder S,
Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH,
Nitsche A, et al: SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2
and is blocked by a clinically proven protease inhibitor. Cell.
181:271–280.e8. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wrapp D, Wang N, Corbett KS, Goldsmith JA,
Hsieh CL, Abiona O, Graham BS and McLellan JS: Cryo-EM structure of
the 2019-nCoV spike in the prefusion conformation. Science.
367:1260–1263. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Rombel-Bryzek A, Miller A and Witkowska D:
Thermodynamic analysis of the interactions between human ACE2 and
spike RBD of Betacoronaviruses (SARS-CoV-1 and SARS-CoV-2). FEBS
Open Bio. 13:174–184. 2023.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Eslami N, Aghbash PS, Shamekh A,
Entezari-Maleki T, Nahand JS, Sales AJ and Baghi HB: SARS-CoV-2:
Receptor and co-receptor Tropism Probability. Curr Microbiol.
79(133)2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lim S, Zhang M and Chang TL:
ACE2-independent alternative receptors for SARS-CoV-2. Viruses.
14(2535)2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Strollo R and Pozzilli P: DPP4 inhibition:
Preventing SARS-CoV-2 infection and/or progression of COVID-19?
Diabetes Metab Res Rev. 36(e3330)2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Raha AA, Chakraborty S, Henderson J,
Mukaetova-Ladinska E, Zaman S, Trowsdale J and Raha-Chowdhury R:
Investigation of CD26, a potential SARS-CoV-2 receptor, as a
biomarker of age and pathology. Biosci Rep.
40(BSR20203092)2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kotani N and Nakano T: Candidate screening
of host cell membrane proteins involved in SARS-CoV-2 entry.
bioRxiv: 2020.09.09.289488, 2020.
|
|
13
|
Parma V, Ohla K, Veldhuizen MG, Niv MY,
Kelly CE, Bakke AJ, Cooper KW, Bouysset C, Pirastu N, Dibattista M,
et al: More than smell-COVID-19 is associated with severe
impairment of smell, taste, and chemesthesis. Chem Senses.
45:609–622. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Cure E and Cumhur Cure M:
Angiotensin-converting enzyme inhibitors and angiotensin receptor
blockers may be harmful in patients with diabetes during COVID-19
pandemic. Diabetes Metab Syndr. 14:349–350. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Long B, Brady WJ, Koyfman A and Gottlieb
M: Cardiovascular complications in COVID-19. Am J Emerg Med.
38:1504–1507. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Mankad K, Perry MD, Mirsky DM and Rossi A:
COVID-19: A primer for neuroradiologists. Neuroradiology.
62:647–648. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Saleki K, Banazadeh M, Saghazadeh A and
Rezaei N: The involvement of the central nervous system in patients
with COVID-19. Rev Neurosci. 31:453–456. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Torabi A, Mohammadbagheri E, Akbari
Dilmaghani N, Bayat AH, Fathi M, Vakili K, Alizadeh R,
Rezaeimirghaed O, Hajiesmaeili M, Ramezani M, et al:
Proinflammatory cytokines in the olfactory mucosa result in
COVID-19 induced anosmia. ACS Chem Neurosci. 11:1909–1913.
2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Samaranayake LP, Fakhruddin KS and
Panduwawala C: Sudden onset, acute loss of taste and smell in
coronavirus disease 2019 (COVID-19): A systematic review. Acta
Odontol Scand. 78:467–473. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Shahbazi R, Yasavoli-Sharahi H, Alsadi N,
Ismail N and Matar C: Probiotics in treatment of viral respiratory
infections and neuroinflammatory disorders. Molecules.
25(4891)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ferguson AV: Circumventricular organs:
integrators of circulating signals controlling hydration, energy
balance, and immune function. In: Neurobiology of Body Fluid
Homeostasis: Transduction and Integration. De Luca LA, Menani JV
and Johnson AK (eds.) CRC Press/Taylor & Francis, Boca Raton
(FL), 2014.
|
|
22
|
Kim J, Alejandro B, Hetman M, Hattab EM,
Joiner J, Schroten H, Ishikawa H and Chung DH: Zika virus infects
pericytes in the choroid plexus and enters the central nervous
system through the blood-cerebrospinal fluid barrier. PLoS Pathog.
16(e1008204)2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Alam SB, Willows S, Kulka M and Sandhu JK:
Severe acute respiratory syndrome coronavirus 2 may be an
underappreciated pathogen of the central nervous system. Eur J
Neurol. 27:2348–2360. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wang F, Wu X, Gao J, Li Y, Zhu Y and Fang
Y: The relationship of olfactory function and clinical traits in
major depressive disorder. Behav Brain Res.
386(112594)2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Yahiaoui-Doktor M, Luck T, Riedel-Heller
SG, Loeffler M, Wirkner K and Engel C: Olfactory function is
associated with cognitive performance: Results from the
population-based LIFE-adult-study. Alzheimers Res Ther.
11(43)2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Li YC, Bai WZ and Hashikawa T: The
neuroinvasive potential of SARS-CoV2 may play a role in the
respiratory failure of COVID-19 patients. J Med Virol. 92:552–555.
2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Li H, Xue Q and Xu X: Involvement of the
nervous system in SARS-CoV-2 infection. Neurotox Res. 38:1–7.
2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Andriuta D, Roger PA, Thibault W, Toublanc
B, Sauzay C, Castelain S, Godefroy O and Brochot E: COVID-19
encephalopathy: Detection of antibodies against SARS-CoV-2 in CSF.
J Neurol. 267:2810–2811. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Sinanović O, Muftić M and Sinanović S:
COVID-19 pandemia: Neuropsychiatric comorbidity and consequences.
Psychiatr Danub. 32:236–244. 2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Xiang P, Xu X, Lu X, Gao L, Wang H, Li Z,
Xiong H, Li R, Xiong Y, Pu L, et al: Case report: Identification of
SARS-CoV-2 in cerebrospinal fluid by ultrahigh-depth sequencing in
a patient with coronavirus disease 2019 and neurological
dysfunction. Front Med (Lausanne). 8(629828)2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Cebrián J, Gonzalez-Martinez A,
García-Blanco MJ, Celdrán-Vivancos D, Palacios EL, Reig-Roselló G,
Casado-Fernández L, Vivancos J and Gago-Veiga AB: Headache and
impaired consciousness level associated with SARS-CoV-2 in CSF: A
case report. Neurology. 95:266–268. 2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Fadakar N, Ghaemmaghami S, Masoompour SM,
Shirazi Yeganeh B, Akbari A, Hooshmandi S and Ostovan VR: A first
case of acute cerebellitis associated with coronavirus disease
(COVID-19): A case report and literature review. Cerebellum.
19:911–914. 2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kremer S, Lersy F, de Sèze J, Ferré JC,
Maamar A, Carsin-Nicol B, Collange O, Bonneville F, Adam G,
Martin-Blondel G, et al: Brain MRI findings in severe COVID-19: A
retrospective observational study. Radiology. 297:E242–E251.
2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Virhammar J, Kumlien E, Fällmar D,
Frithiof R, Jackmann S, Sköld MK, Kadir M, Frick J, Lindeberg J,
Olivero-Reinius H, et al: Acute necrotizing encephalopathy with
SARS-CoV-2 RNA confirmed in cerebrospinal fluid. Neurology.
95:445–449. 2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Azkur AK, Akdis M, Azkur D, Sokolowska M,
van de Veen W, Brüggen MC, O'Mahony L, Gao Y, Nadeau K and Akdis
CA: Immune response to SARS-CoV-2 and mechanisms of
immunopathological changes in COVID-19. Allergy. 75:1564–1581.
2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Tang SW, Helmeste D and Leonard B:
Inflammatory neuropsychiatric disorders and COVID-19
neuroinflammation. Acta Neuropsychiatr. 33:165–177. 2021.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Elieh Ali Komi D, Wöhrl S and Bielory L:
Mast cell biology at molecular level: A comprehensive review. Clin
Rev Allergy Immunol. 58:342–365. 2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Cabrera-Pastor A, Llansola M, Montoliu C,
Malaguarnera M, Balzano T, Taoro-Gonzalez L, García-García R,
Mangas-Losada A, Izquierdo-Altarejos P, Arenas YM, et al:
Peripheral inflammation induces neuroinflammation that alters
neurotransmission and cognitive and motor function in hepatic
encephalopathy: Underlying mechanisms and therapeutic implications.
Acta Physiol (Oxf). 226(e13270)2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Kempuraj D, Ahmed ME, Selvakumar GP,
Thangavel R, Dhaliwal AS, Dubova I, Mentor S, Premkumar K, Saeed D,
Zahoor H, et al: Brain injury-mediated neuroinflammatory response
and Alzheimer's disease. Neuroscientist. 26:134–155.
2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Kempuraj D, Mentor S, Thangavel R, Ahmed
ME, Selvakumar GP, Raikwar SP, Dubova I, Zaheer S, Iyer SS and
Zaheer A: Mast cells in stress, pain, blood-brain barrier,
neuroinflammation and Alzheimer's disease. Front Cell Neurosci.
13(54)2019.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Kempuraj D, Selvakumar GP, Ahmed ME,
Raikwar SP, Thangavel R, Khan A, Zaheer SA, Iyer SS, Burton C,
James D and Zaheer A: COVID-19, mast cells, cytokine storm,
psychological stress, and neuroinflammation. Neuroscientist.
26:402–414. 2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Kustrimovic N, Marino F and Cosentino M:
Peripheral immunity, immunoaging and neuroinflammation in
Parkinson's disease. Curr Med Chem. 26:3719–3753. 2019.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Magrone T, Magrone M, Russo MA and Jirillo
E: Peripheral immunosenescence and central neuroinflammation: A
dangerous liaison-A dietary approach. Endocr Metab Immune Disord
Drug Targets. 20:1391–1411. 2020.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Theoharides TC: Effect of stress on
neuroimmune processes. Clin Ther. 42:1007–1014. 2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Debuc B and Smadja DM: Is COVID-19 a new
hematologic disease? Stem Cell Rev Rep. 17:4–8. 2021.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Wilson MP and Jack AS: Coronavirus disease
2019 (COVID-19) in neurology and neurosurgery: A scoping review of
the early literature. Clin Neurol Neurosurg.
193(105866)2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Nile SH, Nile A, Qiu J, Li L, Jia X and
Kai G: COVID-19: Pathogenesis, cytokine storm and therapeutic
potential of interferons. Cytokine Growth Factor Rev. 53:66–70.
2020.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Karamloo F and König R: SARS-CoV-2
immunogenicity at the crossroads. Allergy. 75:1822–1824.
2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Theoharides TC: COVID-19, pulmonary mast
cells, cytokine storms, and beneficial actions of luteolin.
Biofactors. 46:306–308. 2020.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Kritas SK, Ronconi G, Caraffa A, Gallenga
CE, Ross R and Conti P: Mast cells contribute to
coronavirus-induced inflammation: New anti-inflammatory strategy. J
Biol Regul Homeost Agents. 34:9–14. 2020.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Connell NT, Battinelli EM and Connors JM:
Coagulopathy of COVID-19 and antiphospholipid antibodies. J Thromb
Haemost. 18:E1–E2. 2020.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Markus HS and Brainin M: COVID-19 and
stroke-A global world stroke organization perspective. Int J
Stroke. 15:361–364. 2020.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Khalili N, Haseli S, Bahrami-Motlagh H,
Keshavarz E, Khalili N, Langroudi TF, Khameneh A and Taheri MS:
Neurologic involvement in COVID-19: Radiologists' perspective. Acad
Radiol. 27:1051–1053. 2020.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Qiu H, Wu J, Hong L, Luo Y, Song Q and
Chen D: Clinical and epidemiological features of 36 children with
coronavirus disease 2019 (COVID-19) in Zhejiang, China: An
observational cohort study. Lancet Infect Dis. 20:689–696.
2020.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Zhang J, Xie B and Hashimoto K: Current
status of potential therapeutic candidates for the COVID-19 crisis.
Brain Behav Immun. 87:59–73. 2020.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z
and Zhang Z: D-dimer levels on admission to predict in-hospital
mortality in patients with Covid-19. J Thromb Haemost.
18:1324–1329. 2020.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Connors JM and Levy JH: COVID-19 and its
implications for thrombosis and anticoagulation. Blood.
135:2033–2040. 2020.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Dixon L, Varley J, Gontsarova A, Mallon D,
Tona F, Muir D, Luqmani A, Jenkins IH, Nicholas R, Jones B and
Everitt A: COVID-19-related acute necrotizing encephalopathy with
brain stem involvement in a patient with aplastic anemia. Neurol
Neuroimmunol Neuroinflammation. 7(e789)2020.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Ogier M, Andéol G, Sagui E and Dal Bo G:
How to detect and track chronic neurologic sequelae of COVID-19?
Use of auditory brainstem responses and neuroimaging for long-term
patient follow-up. Brain Behav Immun Health.
5(100081)2020.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Park CL, Russell BS, Fendrich M,
Finkelstein-Fox L, Hutchison M and Becker J: Americans' COVID-19
stress, coping, and adherence to CDC guidelines. J Gen Intern Med.
35:2296–2303. 2020.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Baig AM, Khaleeq A, Ali U and Syeda H:
Evidence of the COVID-19 virus targeting the CNS: Tissue
distribution, host-virus interaction, and proposed neurotropic
mechanisms. ACS Chem Neurosci. 11:995–998. 2020.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Pineton de Chambrun M, Frere C, Miyara M,
Amoura Z, Martin-Toutain I, Mathian A, Hekimian G and Combes A:
High frequency of antiphospholipid antibodies in critically ill
COVID-19 patients: a link with hypercoagulability? J Intern Med.
289:422–424. 2021.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Finsterer J and Stollberger C: Update on
the neurology of COVID-19. J Med Virol. 92:2316–2318.
2020.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Heneka MT, Golenbock D, Latz E, Morgan D
and Brown R: Immediate and long-term consequences of COVID-19
infections for the development of neurological disease. Alzheimers
Res Ther. 12(69)2020.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Leonardi M, Padovani A and McArthur JC:
Neurological manifestations associated with COVID-19: A review and
a call for action. J Neurol. 267:1573–1576. 2020.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Serrano-Castro PJ, Estivill-Torrús G,
Cabezudo-García P, Reyes-Bueno JA, Ciano Petersen N,
Aguilar-Castillo MJ, Suárez-Pérez J, Jiménez-Hernández MD,
Moya-Molina MÁ, Oliver-Martos B, et al: Impact of SARS-CoV-2
infection on neurodegenerative and neuropsychiatric diseases: A
delayed pandemic? Neurologia (Engl Ed). 35:245–251. 2020.PubMed/NCBI View Article : Google Scholar : (In English,
Spanish).
|
|
67
|
Parrella E, Porrini V, Benarese M and
Pizzi M: The role of mast cells in stroke. Cells.
8(437)2019.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Bougakov D, Podell K and Goldberg E:
Multiple neuroinvasive pathways in COVID-19. Mol Neurobiol.
58:564–575. 2021.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Ritchie K, Chan D and Watermeyer T: The
cognitive consequences of the COVID-19 epidemic: Collateral damage?
Brain Commun. 2(fcaa069)2020.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Forkel SJ, Friedrich P, Thiebaut de
Schotten M and Howells H: White matter variability, cognition, and
disorders: A systematic review. Brain Struct Funct. 227:529–544.
2022.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Krause-Utz A, Oei NYL, Niedtfeld I, Bohus
M, Spinhoven P, Schmahl C and Elzinga BM: Influence of emotional
distraction on working memory performance in borderline personality
disorder. Psychol Med. 42:2181–2192. 2012.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Dinakaran D, Manjunatha N, Naveen Kumar C
and Suresh BM: Neuropsychiatric aspects of COVID-19 pandemic: A
selective review. Asian J Psychiatr. 53(102188)2020.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Song E, Zhang C, Israelow B, Lu-Culligan
A, Prado AV, Skriabine S, Lu P, Weizman OE, Liu F, Dai Y, et al:
Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med.
218(e20202135)2021.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Jacob F, Pather SR, Huang WK, Zhang F,
Wong SZH, Zhou H, Cubitt B, Fan W, Chen CZ, Xu M, et al: Human
pluripotent stem cell-derived neural cells and brain organoids
reveal SARS-CoV-2 neurotropism predominates in choroid plexus
epithelium. Cell Stem Cell. 27:937–950.e9. 2020.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Mesci P, Macia A, Saleh A, Martin-Sancho
L, Yin X, Snethlage C, Avansini S, Chanda SK and Muotri A:
Sofosbuvir protects human brain organoids against SARS-CoV-2.
bioRxiv: 2020.05.30.125856, 2020.
|
|
76
|
Ramani A, Müller L, Ostermann PN, Gabriel
E, Abida-Islam P, Müller-Schiffmann A, Mariappan A, Goureau O,
Gruell H, Walker A, et al: SARS-CoV-2 targets neurons of 3D human
brain organoids. EMBO J. 39(e106230)2020.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Oliveira R, Sotero FD and Teodoro T:
NeuroCOVID: Critical review of neuropsychiatric manifestations of
SARS-CoV-2 infection. Ir J Med Sci. 190:851–852. 2021.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q,
Chang J, Hong C, Zhou Y, Wang D, et al: Neurologic manifestations
of hospitalized patients with coronavirus disease 2019 in Wuhan,
China. JAMA Neurol. 77:683–690. 2020.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Banerjee D and Viswanath B:
Neuropsychiatric manifestations of COVID-19 and possible pathogenic
mechanisms: Insights from other coronaviruses. Asian J Psychiatry.
54(102350)2020.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Li J, Long X, Zhang Q, Fang X, Fang F, Lv
X, Zhang D, Sun Y, Li N, Hu S, et al: Emerging evidence for
neuropsycho-consequences of COVID-19. Curr Neuropharmacol.
19:92–96. 2021.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Sozzi M, Algeri L, Corsano M, Crivelli D,
Daga MA, Fumagalli F, Gemignani P, Granieri MC, Inzaghi MG, Pala F,
et al: Neuropsychology in the times of COVID-19 the role of the
psychologist in taking charge of patients with alterations of
cognitive functions. Front Neurol. 11(573207)2020.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Helms J, Kremer S, Merdji H, Clere-Jehl R,
Schenck M, Kummerlen C, Collange O, Boulay C, Fafi-Kremer S, Ohana
M, et al: Neurologic features in severe SARS-CoV-2 infection. N
Engl J Med. 382:2268–2270. 2020.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Zhou H, Lu S, Chen J, Wei N, Wang D, Lyu
H, Shi C and Hu S: The landscape of cognitive function in recovered
COVID-19 patients. J Psychiatr Res. 129:98–102. 2020.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Vinkers CH, van Amelsvoort T, Bisson JI,
Branchi I, Cryan JF, Domschke K, Howes OD, Manchia M, Pinto L, de
Quervain D, et al: Stress resilience during the coronavirus
pandemic. Eur Neuropsychopharmacol. 35:12–16. 2020.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Steenblock C, Todorov V, Kanczkowski W,
Eisenhofer G, Schedl A, Wong ML, Licinio J, Bauer M, Young AH,
Gainetdinov RR and Bornstein SR: Severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis. Mol
Psychiatry. 25:1611–1617. 2020.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Ye Q, Wang B and Mao J: The pathogenesis
and treatment of the ‘Cytokine Storm’ in COVID-19. J Infect.
80:607–613. 2020.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Kempuraj D, Ahmed ME, Selvakumar GP,
Thangavel R, Raikwar SP, Zaheer SA, Iyer SS, Burton C, James D and
Zaheer A: Psychological stress-induced immune response and risk of
Alzheimer's disease in veterans from operation enduring freedom and
operation iraqi freedom. Clin Ther. 42:974–982. 2020.PubMed/NCBI View Article : Google Scholar
|
|
88
|
De Felice FG, Tovar-Moll F, Moll J, Munoz
DP and Ferreira ST: Severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) and the central nervous system. Trends Neurosci.
43:355–357. 2020.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Sheraton M, Deo N, Kashyap R and Surani S:
A review of neurological complications of COVID-19. Cureus.
12(e8192)2020.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Lechien JR, Chiesa-Estomba CM, De Siati
DR, Horoi M, Le Bon SD, Rodriguez A, Dequanter D, Blecic S, El Afia
F, Distinguin L, et al: Olfactory and gustatory dysfunctions as a
clinical presentation of mild-to-moderate forms of the coronavirus
disease (COVID-19): A multicenter European study. Eur Arch
Otorhinolaryngol. 277:2251–2261. 2020.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Barlow A, Landolf KM, Barlow B, Yeung SYA,
Heavner JJ, Claassen CW and Heavner MS: Review of emerging
pharmacotherapy for the treatment of coronavirus disease 2019.
Pharmacotherapy. 40:416–437. 2020.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Gigante A, Aquili A, Farinelli L, Caraffa
A, Ronconi G, Enrica Gallenga C, Tetè G, Kritas SK and Conti P:
Sodium chromo-glycate and palmitoylethanolamide: A possible
strategy to treat mast cell-induced lung inflammation in COVID-19.
Med Hypotheses. 143(109856)2020.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Conti P, Gallenga CE, Tetè G, Caraffa A,
Ronconi G, Younes A, Toniato E, Ross R and Kritas SK: How to reduce
the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection
and lung inflammation mediated by IL-1. J Biol Regul Homeost
Agents. 34:333–338. 2020.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Negrini F, Ferrario I, Mazziotti D,
Berchicci M, Bonazzi M, de Sire A, Negrini S and Zapparoli L:
Neuropsychological features of severe hospitalized coronavirus
disease 2019 patients at clinical stability and clues for postacute
rehabilitation. Arch Phys Med Rehabil. 102:155–158. 2021.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Verkhratsky A, Li Q, Melino S, Melino G
and Shi Y: Can COVID-19 pandemic boost the epidemic of
neurodegenerative diseases? Biol Direct. 15(28)2020.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Minihan E, Gavin B, Kelly BD and
McNicholas F: COVID-19, mental health and psychological first aid.
Ir J Psychol Med. 37:259–263. 2020.PubMed/NCBI View Article : Google Scholar
|
